155 related articles for article (PubMed ID: 36259719)
1. Impact of redo ablation for atrial fibrillation on patient-reported outcomes and quality of life.
Farwati M; Amin M; Saliba WI; Nakagawa H; Tarakji KG; Diab M; Scandinaro A; Madden R; Bouscher P; Kuroda S; Kanj M; Dresing TJ; Callahan TD; Bhargava M; Sroubek J; Baranowski B; Rickard J; Cantillon DJ; Tchou PJ; Wazni OM; Hussein AA
J Cardiovasc Electrophysiol; 2023 Jan; 34(1):54-61. PubMed ID: 36259719
[TBL] [Abstract][Full Text] [Related]
2. Atrial Fibrillation Ablation in Young Adults: Measuring Quality of Life Using Patient-Reported Outcomes Over 5 Years.
Johnson BM; Wazni OM; Farwati M; Saliba WI; Santangeli P; Madden R; Bouscher P; Chung M; Kanj M; Dresing TJ; Callahan TD; Bhargava M; Baranowski B; Rickard J; Cantillon DJ; Tchou PJ; Sroubek J; Nakagawa H; Hussein AA
Circ Arrhythm Electrophysiol; 2023 Jun; 16(6):e011565. PubMed ID: 37183675
[TBL] [Abstract][Full Text] [Related]
3. New Model of Automated Patient-Reported Outcomes Applied in Atrial Fibrillation.
Hussein AA; Lindsay B; Madden R; Martin D; Saliba WI; Tarakji KG; Saqi B; Rausch DJ; Dresing T; Callahan T; Chung MK; Baranowski B; Bhargava M; Cantillon D; Rickard J; Kanj M; Tchou P; Wilkoff BL; Nissen SE; Wazni OM
Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e006986. PubMed ID: 30866665
[TBL] [Abstract][Full Text] [Related]
4. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Mark DB; Anstrom KJ; Sheng S; Piccini JP; Baloch KN; Monahan KH; Daniels MR; Bahnson TD; Poole JE; Rosenberg Y; Lee KL; Packer DL;
JAMA; 2019 Apr; 321(13):1275-1285. PubMed ID: 30874716
[TBL] [Abstract][Full Text] [Related]
5. Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life.
Tabaja C; Younis A; Santageli P; Farwati M; Braghieri L; Nakagawa H; Saliba WI; Madden R; Bouscher P; Kanj M; Callahan TD; Martin D; Bhargava M; Chung M; Baranowski B; Nakhla S; Sroubek J; Lee J; Taigen T; Wazni OM; Hussein AA
J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1648-1657. PubMed ID: 37493505
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
Gupta D; Vijgen J; Potter T; Scherr D; Van Herendael H; Knecht S; Kobza R; Berte B; Sandgaard N; Albenque JP; Széplaki G; Stevenhagen Y; Taghji P; Wright M; Duytschaever M
Heart; 2021 Aug; 107(16):1296-1302. PubMed ID: 33952593
[TBL] [Abstract][Full Text] [Related]
7. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.
Boersma L; Koźluk E; Maglia G; de Sousa J; Grebe O; Eckardt L; Hokanson RB; Hemingway LA; Ostern E; Park HS; Rovaris G; Arribas F; Scharf C; Csanádi Z; Arenal Á; Laurenzi F; Klaver M; Goette A
Europace; 2020 Jun; 22(6):888-896. PubMed ID: 32219388
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of atrial fibrillation ablation in patients with or without silent pulmonary veins from prior ablation procedure.
Aguilera J; Hutt E; Kaur S; Saliba WI; Tarakji KG; Baranowski B; Bhargava M; Kanj M; Cantillon DJ; Rickard J; Sroubek J; Nakagawa H; Wazni OM; Hussein AA
J Cardiovasc Electrophysiol; 2022 Sep; 33(9):1994-2000. PubMed ID: 35689504
[TBL] [Abstract][Full Text] [Related]
9. Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation: Substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) Randomized Clinical Trial.
Samuel M; Khairy P; Champagne J; Deyell MW; Macle L; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Tardif JC; Andrade JG
JAMA Cardiol; 2021 Nov; 6(11):1324-1328. PubMed ID: 34406350
[TBL] [Abstract][Full Text] [Related]
10. Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.
Zeitler EP; Li Y; Silverstein AP; Russo AM; Poole JE; Daniels MR; Al-Khalidi HR; Lee KL; Bahnson TD; Anstrom KJ; Packer DL; Mark DB;
J Am Heart Assoc; 2023 Feb; 12(3):e027871. PubMed ID: 36688367
[TBL] [Abstract][Full Text] [Related]
11. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
[TBL] [Abstract][Full Text] [Related]
12. Long term outcomes from catheter ablation of very longstanding persistent atrial fibrillation.
Phillips KP; Walker DT
Int J Cardiol; 2017 Feb; 228():865-869. PubMed ID: 27889553
[TBL] [Abstract][Full Text] [Related]
13. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
[TBL] [Abstract][Full Text] [Related]
14. Effect of left atrial ablation on the quality of life in patients with atrial fibrillation.
Miyazaki S; Kuwahara T; Takahashi A; Kobori A; Takahashi Y; Nozato T; Hikita H; Sato A; Aonuma K; Hirao K; Isobe M
Circ J; 2008 Apr; 72(4):582-7. PubMed ID: 18362429
[TBL] [Abstract][Full Text] [Related]
15. Association Between Quality of Life and Procedural Outcome After Catheter Ablation for Atrial Fibrillation: A Secondary Analysis of a Randomized Clinical Trial.
Terricabras M; Mantovan R; Jiang CY; Betts TR; Chen J; Deisenhofer I; Macle L; Morillo CA; Haverkamp W; Weerasooriya R; Albenque JP; Nardi S; Menardi E; Novak P; Sanders P; Verma A;
JAMA Netw Open; 2020 Dec; 3(12):e2025473. PubMed ID: 33275151
[TBL] [Abstract][Full Text] [Related]
16. Convergent ablation for persistent atrial fibrillation: outcomes from a single-centre real-world experience.
Mannakkara NN; Porter B; Child N; Sidhu BS; Mehta VS; Elliott MK; Gould J; Ahmed S; Razavi R; Rinaldi CA; Blauth C; Gill JS
Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36346176
[TBL] [Abstract][Full Text] [Related]
17. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
Monahan KH; Bunch TJ; Mark DB; Poole JE; Bahnson TD; Al-Khalidi HR; Silverstein AP; Daniels MR; Lee KL; Packer DL;
Europace; 2022 Oct; 24(9):1430-1440. PubMed ID: 35640922
[TBL] [Abstract][Full Text] [Related]
18. [Health-related quality of life of patients with atrial fibrillation managed by cardiologists: MOVE study].
Kirch W; Pittrow D; Bosch RF; Kohlhaussen A; Willich SN; Rosin L; Bonnemeier H;
Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S26-32. PubMed ID: 20221975
[TBL] [Abstract][Full Text] [Related]
19. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
[TBL] [Abstract][Full Text] [Related]
20. Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study.
Essebag V; Azizi Z; Alipour P; Khaykin Y; Leong-Sit P; Sarrazin JF; Sturmer M; Morillo C; Terricabras M; Amit G; Roux JF; Patterson S; Verma A
Europace; 2020 Jul; 22(7):1017-1025. PubMed ID: 32531030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
